April 2024 in “Benha Medical Journal” H. pylori infection may be linked to the hair shedding condition Telogen Effluvium.
April 2024 in “BENTHAM SCIENCE PUBLISHERS eBooks” The document's conclusion cannot be provided because the document is not readable or understandable.
March 2024 in “International journal of research in medical sciences” Dr. SKS hair booster serum effectively treats hair loss caused by COVID-19.
March 2024 in “CRC Press eBooks” Telogen effluvium is a type of hair loss where more hair than normal falls out after stress or illness.
March 2024 in “Homoeopathic links” Individualized homeopathic treatment led to complete hair regrowth in a patient with stress-induced hair loss.
March 2024 in “Indian Journal of Dermatology” Iron supplements may improve hair loss satisfaction even if initial iron levels are normal.
March 2024 in “Buletin de psihiatrie integrativă (Print)” Hair loss from telogen effluvium can cause mental health issues and lower life quality, needing both medical and emotional support.
March 2024 in “Advancements in Homeopathic Research” Homoeopathy has helped treat hair loss after Covid-19, considering the patient's overall condition.
Many severe COVID-19 patients experienced temporary hair loss, but most regrew hair within six months.
January 2024 in “Annals of Agricultural and Environmental Medicine” Red LED light therapy helps reduce hair loss and improves hair regrowth in long COVID patients.
January 2024 in “Medicine” Hypothyroidism is often linked to the hair loss condition telogen effluvium.
Some blood thinners and blood pressure medicines can cause hair loss, which usually starts 1 to 6 months after beginning the medication.
January 2024 in “Annals of dermatology/Annals of Dermatology” Weight loss can cause temporary hair loss, especially in women and older adults.
December 2023 in “Damianus Journal of Medicine” Post-COVID-19 patients are at risk for hair loss.
Some medications, including retinoids, antifungals, and psychotropic drugs, can cause reversible hair loss if stopped or doses are reduced.
November 2023 in “Italian journal of dermatology and venereology” Telogen effluvium is a common, often temporary hair loss caused by stress and other factors, and it's hard to pinpoint and treat.
November 2023 in “Stem cells and cloning” A new treatment using stem cell-conditioned media significantly improved hair growth in people with temporary hair loss.
September 2023 in “International Journal of Trichology” Oral Vitamin D can improve hair density and reduce hair loss in Telogen Effluvium patients.
August 2023 in “Benha Journal of Applied Sciences” COVID-19 survivors working in healthcare may experience temporary hair loss.
COVID-19 infection is highly related to increased hair loss, especially in women.
July 2023 in “Dermatology practical & conceptual” Low hemoglobin levels are significantly correlated with hair loss in women with Telogen Effluvium.
July 2023 in “Regenerative Therapy” Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.
July 2023 in “Chinese Journal of Dermatology” COVID-19 may cause common hair loss due to stress, immune response, medications, and other health issues.
June 2023 in “Benha Journal of Applied Sciences” People with chronic hair shedding have lower antioxidant levels in their blood compared to healthy individuals.
June 2023 in “GALENICAL Jurnal Kedokteran dan Kesehatan Mahasiswa Malikussaleh” Telogen effluvium is a form of hair loss caused by various factors and requires identifying the cause for proper treatment.
June 2023 in “Skin Research and Technology” The supplement with amino acids, iron, selenium, and marine hydrolyzed collagen improved hair growth more than drug treatment alone, with most people tolerating it well.
June 2023 in “Italian journal of dermatology and venereology” The oral supplement improved hair loss in patients with telogen effluvium.
June 2023 in “Annals of the College of Medecine” Low iron levels are linked to more hair loss in women with chronic hair shedding.
May 2023 in “Journal of contemporary medicine” Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.
May 2023 in “Journal of The American Academy of Dermatology” Most lab tests for patients with Telogen effluvium, a type of hair loss, show no or mild abnormalities; only a few specific tests are useful.